PGD Antibodies

Santa Cruz Biotechnology delivers a wide array of PGD Antibodies for investigating phosphogluconate dehydrogenase (PGD) in various biological processes. PGD Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Phosphogluconate dehydrogenase (PGD) is a key enzyme in the pentose phosphate pathway, playing a crucial role in cellular metabolism by generating NADPH and ribose-5-phosphate. PGD maintains cellular redox balance and provides necessary precursors for nucleotide synthesis, making it vital for cell proliferation and survival. Research has shown that PGD activity influences various cellular processes, from energy metabolism to biosynthetic pathways. Understanding PGD function has significant implications for metabolic disorders and cancer biology. Recent studies have highlighted PGD as a potential therapeutic target in multiple disease states. Investigating PGD expression and activity patterns can reveal new insights into cellular metabolism and disease progression. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of PGD's role in health and disease.